INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
146 hedge funds and large institutions have $1.1B invested in Insys Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 41 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+13
Holders Change %
+9.77%
% of All Funds
3.94%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
32
Increased
63
Reduced
41
Closed
19
Calls
$44.3M
Puts
$72.8M
Net Calls
-$28.6M
Net Calls Change
-$30.4M
Top Buyers
| 1 |
SCM
1
Scopia Capital Management
New York
|
$31.3M |
| 2 |
BTP
2
Bloom Tree Partners
New York
|
$25.3M |
| 3 |
GT
3
Glenmede Trust
Philadelphia,
Pennsylvania
|
$18.1M |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$34.6M |
| 5 |
CCM
5
Consonance Capital Management
New York
|
$107M |
